29th March 2022
BioCurity Pharmaceuticals Inc. (‘BioCurity’ or ‘Company’) Announces Notice of Allowance for the Company’s United States Patent Claims on Reduction of Side Effects Caused by Radiation Therapy Combined with Chemotherapy Business Wire
